SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen Multi-Market Income Fund (JMM) trades at a trailing P/E of 12.4. Trailing earnings yield is 8.10%. PEG 0.62 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (12.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.62); earnings yield beats bond yields (8.10%).
- PEG Ratio 0.62 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.10% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 74/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JMM
Valuation Multiples
P/E (TTM)12.4
Forward P/EN/A
PEG Ratio0.62
Forward PEGN/A
P/B Ratio0.00
P/S Ratio9.31
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.48
Book Value / Share$0.00
Revenue / Share$0.64
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.10%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.14 |
$4.85M |
$1.37M |
28.2% |
| 2016 |
$5,993,590.00 |
$3.77M |
$3.09M |
82% |
| 2017 |
$0.22 |
$2.23M |
$2.04M |
91.5% |
| 2018 |
$0.41 |
$4.05M |
$3.84M |
94.8% |
| 2019 |
$-0.19 |
$-1.57M |
$-1.77M |
- |
| 2020 |
$0.67 |
$6.53M |
$6.32M |
96.8% |
| 2021 |
$-0.91 |
$-8.34M |
$-8.57M |
- |
| 2022 |
$0.17 |
$1.82M |
$1.57M |
86% |
| 2023 |
$0.40 |
$4.62M |
$3.75M |
81.3% |
| 2024 |
$0.48 |
$6.03M |
$4.54M |
75.4% |
